For research use only. Not for therapeutic Use.
ASN02563583, a compound that regulates the activity of the GPR17 receptor, has a IC50 value of 0.64 nM in [35S]GTPγS binding assay. ASN02563583 can be used in the study of neurological diseases[1].
| Catalog Number | I040087 |
| CAS Number | 483283-39-2 |
| Synonyms | 2-[[5-(2-methoxyphenyl)-4-(4-methoxyphenyl)-1,2,4-triazol-3-yl]sulfanyl]-N-phenylpropanamide |
| Molecular Formula | C25H24N4O3S |
| Purity | ≥95% |
| InChI | InChI=1S/C25H24N4O3S/c1-17(24(30)26-18-9-5-4-6-10-18)33-25-28-27-23(21-11-7-8-12-22(21)32-3)29(25)19-13-15-20(31-2)16-14-19/h4-17H,1-3H3,(H,26,30) |
| InChIKey | KGGHSILNBGUJEN-UHFFFAOYSA-N |
| SMILES | CC(C(=O)NC1=CC=CC=C1)SC2=NN=C(N2C3=CC=C(C=C3)OC)C4=CC=CC=C4OC |
| Reference | [1]. Mariapia Abbracchio, et al. TGpr17-modulating compounds, diagnostic and therapeutic uses thereof. US20140148472A1. 2014-05-29. |
